Detalhe da pesquisa
1.
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Oncology;
102(1): 30-42, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37598676
2.
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Invest New Drugs;
40(5): 1066-1079, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35749041
3.
Luminal Findings of a Bronchogenic Cyst.
Am J Respir Crit Care Med;
204(6): e59-e60, 2021 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33882265
4.
Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer.
Intern Med;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38749728
5.
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.
Cancer Med;
12(1): 73-83, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35699088
6.
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Thorac Cancer;
14(25): 2567-2578, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37469246
7.
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.
Thorac Cancer;
13(14): 2031-2040, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35616056
8.
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Thorac Cancer;
13(19): 2776-2785, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36062426
9.
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
Front Oncol;
12: 1080729, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36741711
10.
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity.
Respir Investig;
59(2): 247-251, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33189601
11.
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Thorac Cancer;
11(10): 2867-2876, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32844570
12.
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
J Cancer Res Clin Oncol;
146(2): 457-466, 2020 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31853661
13.
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
Cancer Chemother Pharmacol;
85(4): 761-771, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32193618
14.
Wheezing and Weightlifting.
Intern Med;
61(6): 931-932, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34483215
15.
Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography.
Intern Med;
58(23): 3487-3488, 2019 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31327841